Caplight Directory>Investors>Hikma Ventures>Hikmaventures


Hikma Ventures

Hikma Ventures

London, Englandhikmaventures.com

Overview

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide . They invest in disruptive technologies and companies that can make a real difference for Hikma and their portfolio companies . Their investment mandate is broad, with focus areas including drug delivery, digital therapeutics, clinical trial innovation, respiratory, CNS, oncology, and certain autoimmune and chronic diseases .

Year Founded

2015

Portfolio Companies

16

Investments

CompanyDateStageLead
Octave BioscienceSep 2025Series CCo-investor
BiolinqApr 2025Series CCo-investor
i2o TherapeuticsAug 2023Series ACo-investor
Octave BioscienceJul 2023Series B ExtensionCo-investor
Altoida, Inc.Mar 2022Series A ExtensionCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.